Quote

Still, generic manufacturers have already made commitments to ramp up production of hydroxychloroquine. In her note, Fadia wrote that Amneal Pharmaceuticals (AMRX) has said it will make 20 million pills by mid-April, Mylan (MYL) could provide 50 million pills using the ingredients it has available, Teva Pharmaceutical Industries (TEVA) will ship 6 million pills by the end of March and more than 10 million in total within a month. Novartis (NVS) subsidiary Sandoz has said it will donate 130 million doses if the drug is approved for Covid-19 patients, Fadia wrote.

All told, according to Fadia’s numbers, that would be enough doses for more than 6.7 million patients.